Repurposing azacitidine and carboplatin to prime for anti-PDL1 re-challenge of immunotherapy-resistant melanoma
暂无分享,去创建一个
M. Lyle | R. Vilain | N. Bowden | R. Levy | A. Majid | A. van der Westhuizen | M. Graves | X. Zhu | L. Pugliese | K. Cornall | J. Wong | S. Ren | X. Zhu